Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Find the Marvels of the World with These Travels - 22026 Golden Globes: How to watch, start time, TV channel, full nominee list and more
- 3Top Frozen yogurt Flavor: Cast Your Vote!
- 4Doctor's orders: Eat ice cream, and other tips for a long and healthy life
- 5The 15 Most Rousing TED Chats on Self-awareness
- Blood pressure drug recalled for possible cross-contamination
- Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- Best Pizza Beating: What's Your #1?
- Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- Climbing Mount Everest: An Individual Victory
- IDF Givati Brigade soldier arrested, charged in suspected Iran espionage
- 5 Movies That Leaving an Imprint with Inventive Innovation
